Core lab

Integrated, connected laboratories: A new era in lab testing led by science, grounded in clinical evidence, supported by a patient-centric partnership

Our innovative end-to-end solutions—from stand-alone analyzers to fully integrated lab solutions, complemented by simplified workflows—help increase throughput under demanding time constraints.

Next-generation core lab solutions utilize the innovative Elecsys® technology and high-quality standardized reagents, enabling laboratories to achieve fast, accurate, and reliable results with streamlined processes across cobas® platform analyzers.

Quality in vitro diagnostic testing and scalable modular systems create a solid foundation for your lab’s success. navify® digital solutions equip modern laboratories with innovative digital technologies that drive operational excellence and secure connectivity, impacting patient care and helping to differentiate your lab. 

Partnering with Roche means you will never be alone in your business journey.

True integration to achieve maximum operational effectiveness—backed by science, driven by simplicity, and delivered through partnership

Roche’s innovative diagnostics solutions enable labs to combine immunodiagnostics and clinical chemistry in a single serum work area. Our integration capabilities extend beyond the core lab for a fully connected and simplified workflow.

The Elecsys® and cobas® menu of fast and reliable assays covers a wide range of diagnostic tests, including infectious diseases, blood screening, cardiometabolic diseases, urinalysis, oncology, women's health, and neurology.

Roche’s cutting-edge automation technology reduces time-consuming manual work, such as pre-and-post-analytical tasks and sample transportation, to maximize your efficiency and productivity.

Supporting improved patient outcomes with high-quality, reliable assays and efficient end-to-end diagnostic testing

At Roche, we prioritize patient care and increasing medical value, delivering diagnostic breakthroughs that empower laboratories to lead with confidence and adapt to future opportunities and challenges.

Through our ongoing investments, we continue to expand our offerings of assays, immunoassays, biomarkers, and clinical algorithms, all with the purpose of helping clinicians make the best possible decisions to improve patient outcomes.

Roche is deeply committed to the fight against Alzheimer's disease, sepsis, hemophilia, thrombosis, and infectious and cardiovascular diseases, among others, and to help advance care in other areas, such as blood screening and mass spectrometry.